Sinovac BiotechvsUnitedHealth

SVA and UNH stock compared: price, dividend, valuation and results, from SEC filings.

UNH

UnitedHealth Group Incorporated

$330.48

Value $300B

-5.55%
UNH's page

Sinovac Biotech (SVA) has a market value of $465M and UnitedHealth (UNH) $300B. Dividend yield: SVA none, UNH 2.74%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    SVA$465M

    UNH$300B

    UNH is 645 times SVA

  • Revenue, 12 months

    SVA$386M

    UNH$450B

    UNH is 1,165 times SVA

  • Net income, 12 months

    SVA-$60M

    UNH$15.9B

  • Operating margin

    SVA-127.0%

    UNH5.3%

    132.3 points apart

  • ROIC

    SVA-7.9%

    UNH11.3%

    19.1 points apart

  • P/E

    SVA–

    UNH18.9

  • Dividend yield

    SVA0.0%

    UNH2.7%

    2.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

Prices are not available right now.

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

SVASinovac BiotechUNHUnitedHealth

Valuation

SVAUNH
Valuation
Price$6.47$330.48
Market value$465M$300B
Enterprise value (EV)–$346B
P/E–18.9
P/E, 5-year median–25.0
P/B0.12.9
EV/EBIT–14.5
Free cash flow yield–7.6%

Results and growth

SVAUNH
Results and growth
Revenue, 12 months$386M$450B
Net income, 12 months-$60M$15.9B
Free cash flow, 12 months-$561M$22.8B
Earnings per share, 12 months-$0.83$17.52
Revenue growth, year on year6.8%11.8%
Revenue growth a year, past-5.4%over 5 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

SVAUNH
Margins and returns on capital
Gross margin67.9%88.3%
Operating margin-127.0%5.3%
Net margin-15.5%3.5%
ROIC-7.9%11.3%
ROE-1.3%15.5%

Balance sheet

SVAUNH
Balance sheet
Cash$6.0B$28.5B
Total debt$506M$74.3B
Net debt / EBITDA–1.6
Interest cover-49.9×6.2×

Dividends and buybacks

SVAUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months$55.00$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield850.1%4.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: SVA or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Sinovac Biotech or UnitedHealth?

By market value, UnitedHealth ($300B) is about 645.2 times Sinovac Biotech ($465M), at today's prices.

Which pays the higher dividend, SVA or UNH?

The dividend yield at today's price is none for Sinovac Biotech and 2.74% for UnitedHealth. Over the last twelve months they paid $55.00 and $9.06 per share.

Which has the higher profit margins, Sinovac Biotech or UnitedHealth?

Over the last twelve months, the net margin was -15.5% for Sinovac Biotech and 3.5% for UnitedHealth, and the operating margin -127.0% and 5.3%. Revenue was $386M and $450B.

Which is the better investment, Sinovac Biotech or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.